Table 1 The main constituents of Triphala and their potential therapeutic effects
Botanical (Hindi name, English) | Phytochemicals | Percentage of phytochemical in each Triphala constituenta | Indication for therapeutic usage | References |
|---|---|---|---|---|
Terminalia chebula (Harad, Chebulic Myrobalan) | Gallic acid | 0.024% (w/w) | Constipation, hemorrhoid, skin disease, asthma, dysentery, uterine debility, anemia, diabetes, leukoderma, tumors and heart disease | |
Tannic acid | 0.011% (w/w) | |||
Syringic acid | 0.009% (w/w) | |||
Epicatechin | 0.006% (w/w) | |||
Ascorbic acid | 0.020% (w/w) | |||
Chebulinic acid | Unknown | |||
Anthraquinone | Unknown | |||
Phosphoric acid | Unknown | |||
Terminalia bellerica (Baheda, Belliric Myrobalan) | Gallic acid | 0.005% (w/w) | Cough, asthma, anorexia, vomiting, arthritis, fever, epilepsy, splenomegaly, piles, diarrhea, leprosy, brain tonic and laxative | |
Tannic acid | 0.004% (w/w) | |||
Ascorbic acid | 0.023% (w/w) | |||
β-sitosterol | Unknown | |||
Ellagic acid | Unknown | |||
Chebulic acid | Unknown | |||
Mannitol | Unknown | |||
Oxalic acid | Unknown | |||
Galloyl | Unknown | |||
Galactose | Unknown | |||
Fructose | Unknown | |||
Phyllanthus emblica (Amala, Emblic Myrobalan) | Ascorbic acid | 0.036% (w/w) | Diabetes, hysteria, jaundice, eczema, piles, diarrhea, menorrhagia, scurvy, rebuilds and maintains new tissues and increases red blood counts | |
Gallic acid | 0.081% (w/w) | |||
Nicotinic acid | Unknown | |||
Ellagic acid | Unknown | |||
Linoleic acid | Unknown | |||
Linolenic acid | Unknown | |||
Oleic acid | Unknown |